Archean Chemical Industries Ltd

Archean Chemical Q2 Update: SOP Trials Succeed, Bromine Growth Ahead 🚀

- Sulphate of Potash (SOP) pilot trials successful; commercial production expected post-monsoon 2026.

- Bromine derivatives running at 30-35% capacity, targeting 50% by FY26-end.

- Industrial salt sales at 0.9M metric tons in Q2 (65% of revenue); full-year export target: 4.5M tons.

- Oren Hydrocarbon (now Idealis Mudchemie) revenue contributions expected from FY27.

- India Semiconductor Mission approved SiCSem project; Phase 1 investment: ₹2,067 crores.

- Invested in Offgrid Energy Labs (18.14% stake) for Zinc Bromide battery tech; 10 MWh UK demo planned.

- Q2 standalone revenue: ₹2,317.8M (-8% YoY), EBITDA margin at 33%.

- H1 standalone revenue: ₹5,232.3M (+10% YoY), net profit up 28% to ₹903.1M.

- Consolidated H1 revenue: ₹5,401.5M, EBITDA: ₹1,553M.

- Net debt-free with ₹190 crores spent on bromine capex (out of ₹250 crores planned).

- Income tax search conducted in Sept 2025; company cooperated fully.